One form of juvenile onset autosomal recessive amyotrophic lateral sclerosis (ALS2) has been linked to the dysfunction of the ALS2 gene. The ALS2 gene is expressed in lymphoblasts, however, whether ALS2-deficiency affects periphery blood is unclear. Here we report that ALS2 knockout (ALS2 −/− ) mice developed peripheral lymphopenia but had higher proportions of hematopoietic stem and progenitor cells in which the stem cell factor-induced cell proliferation was up-regulated. Our findings reveal a novel function of the ALS2 gene in the lymphopoiesis and hematopoiesis, suggesting that the immune system is involved in the pathogenesis of ALS2.
Introduction
Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease caused by a selective loss of lower and upper motor neurons in the central nerve system (CNS) (Cleveland and Rothstein, 2001) . Recently, mutations in a second ALS-related gene (ALS2) were identified, which cause a rare recessive form of juvenile onset ALS (ALS2) (Hadano et al., 2001; Yang et al., 2001) , adding onto the previously defined mutations in the copper/zinc superoxide dismutase 1-(SOD1) (Rosen, 1993) . The fact that both SOD1 and ALS2 gene are expressed in a broad range of cell types in different tissues of various animal species led us to believe that mutations in these genes may affect systems other than the CNS. One of the systems warrants further investigation is the lymphohematopoietic system. A direct link between ALS and the lymphohematopoietic system comes from the clinical observation that ALS patients had marked lymphopenia with reductions in CD2 + and CD8 + T cells in comparison to age-matched normal controls (Provinciali et al., 1988) . The "ALS"-like disorder seen in patients with HIV infection further suggests that reduced immunity with viral infection might be a key element in the pathogenesis of ALS (Verma and Berger, 2006; Sinha et al., 2004) . Most recently, a significant decrease of white blood cells was observed in the SOD1 G93A transgenic mouse model of ALS, further supporting the role of immunodeficiency in ALS (Kuzmenok et al., 2006) . However, whether ALS2-deficiency affects immune system is not clear.
Previously, we along with others have developed a mouse model of ALS2 by generation of ALS2 knockout (ALS2 −/− ) mice (Cai et al., 2005; Hadano et al., 2006; Devon et al., 2006; Yamanaka et al., 2006 
